Biochips market seen reaching $29.03 billion by 2030

The biochips market is projected to grow from $16.97 billion in 2026 to $29.03 billion by 2030, according to The Business Research Company. Demand for precision medicine, lab-on-chip diagnostics and biomarker research is shaping the next phase of growth, with North America leading today and Asia-Pacific expected to grow fastest.

Why it matters: - Biochips are becoming a core tool in diagnostics, genetic sequencing and biotechnology research. - The market’s projected rise to $29.03 billion by 2030 points to sustained demand across healthcare, life sciences and drug development. - Growth in personalized medicine and lab-on-chip testing could expand how quickly clinicians and researchers use biochip-based tools.

What happened: - The Business Research Company projected the global biochips market will rise from $16.97 billion in 2026 to $29.03 billion by 2030. - The forecast implies a 14.4% compound annual growth rate over the period. - The company said the market was valued at $14.61 billion in 2025 and is expected to reach $16.97 billion in 2026, reflecting 16.1% growth in that year. - The report was released July 29, 2026, from London.

The details: - Biochips are compact devices that place arrays of biological molecules, including DNA, proteins or cells, on a solid surface. - The devices combine biological components with electronic systems to analyze and manage biological information. - The market’s historical growth has been tied to genomics and proteomics research, pharmaceutical and biotech R&D, DNA microarray adoption in genetic screening, molecular diagnostics use and microarray and microfluidic analytical platforms. - Future growth is expected to come from precision medicine, personalized therapies, lab-on-chip use in clinical diagnostics, biomarker discovery, translational research, agriculture and life sciences applications, and commercialization of advanced diagnostic tools. - The report highlighted genetic sequencing, disease diagnostics, protein and cell arrays, point-of-care testing, drug discovery, device miniaturization and high-throughput biological data analysis as key trends. - North America held the largest market share in 2025. - Asia-Pacific is projected to be the fastest-growing regional market during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The Business Research Company also said its 2026 market reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated technology and trend analysis. - The company offered a free sample report and the full report through the company’s sample page and the full market report.

Between the lines: - The forecast suggests biochips are moving from a niche research tool toward a broader commercial platform for diagnostics and personalized treatment. - The strongest demand signal appears to be healthcare use, but the inclusion of agriculture and life sciences shows the market’s reach is widening beyond medicine. - Regional leadership remains with North America, but faster growth in Asia-Pacific points to a shift in where future expansion may be concentrated.

What's next: - The market is expected to keep expanding through 2030 as precision medicine and point-of-care diagnostics gain adoption. - Advances in miniaturization and data analysis should support more sophisticated biochip applications. - Investors and suppliers will likely watch biomarker discovery, translational research and lab-on-chip commercialization for the next wave of demand.

The bottom line: - Biochips are on track for steady double-digit growth, driven by healthcare demand, broader research use and faster adoption of diagnostic technologies.